In vitro fosfomycin activity in vancomycin-resistant Enterococcus faecalis. 2009

Silvana Superti, and Cícero Armídio Gomes Dias, and Pedro Alves d'Azevedo
Program in Pathology of Health Sciences, Federal University of Porto Alegre, Rua Sarmento Leite 245/204, Porto Alegre, RS, Brazil.

Enterococci are part of the endogenous flora of human beings, are naturally resistant to several classes of antimicrobials, and are able to acquire resistance with relative ease. Currently the vancomycin-resistant enterococci are spread all over the world and treatment options for infections caused by it are often extremely limited. We assessed 193 vancomycin-resistant Enterococcus faecalis isolates collected from four different hospitals in Porto Alegre for their susceptibility to fosfomycin using the E-test and agar diffusion. Fosfomycin proved to be active in vitro against the great majority of isolates, indicating that it is a valid option in the treatment of these infections.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D005578 Fosfomycin An antibiotic produced by Streptomyces fradiae. Phosphonomycin,Fosfomycin Trometamol Salt,Fosfomycin Tromethamine,Monuril,Phosphomycin,Tromethamine, Fosfomycin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013293 Enterococcus faecalis A species of gram-positive, coccoid bacteria commonly isolated from clinical specimens and the human intestinal tract. Most strains are nonhemolytic. Streptococcus Group D,Streptococcus faecalis
D020713 Vancomycin Resistance Nonsusceptibility of bacteria to the action of VANCOMYCIN, an inhibitor of cell wall synthesis.

Related Publications

Silvana Superti, and Cícero Armídio Gomes Dias, and Pedro Alves d'Azevedo
December 2020, Infectious diseases and therapy,
Silvana Superti, and Cícero Armídio Gomes Dias, and Pedro Alves d'Azevedo
September 1996, The Medical journal of Australia,
Silvana Superti, and Cícero Armídio Gomes Dias, and Pedro Alves d'Azevedo
September 1989, Antimicrobial agents and chemotherapy,
Silvana Superti, and Cícero Armídio Gomes Dias, and Pedro Alves d'Azevedo
January 2004, Emerging infectious diseases,
Silvana Superti, and Cícero Armídio Gomes Dias, and Pedro Alves d'Azevedo
March 2008, International journal of antimicrobial agents,
Silvana Superti, and Cícero Armídio Gomes Dias, and Pedro Alves d'Azevedo
October 2004, Antimicrobial agents and chemotherapy,
Silvana Superti, and Cícero Armídio Gomes Dias, and Pedro Alves d'Azevedo
October 2013, The Journal of antibiotics,
Silvana Superti, and Cícero Armídio Gomes Dias, and Pedro Alves d'Azevedo
February 1999, The Journal of antimicrobial chemotherapy,
Silvana Superti, and Cícero Armídio Gomes Dias, and Pedro Alves d'Azevedo
January 1995, Acta clinica Belgica,
Silvana Superti, and Cícero Armídio Gomes Dias, and Pedro Alves d'Azevedo
April 1996, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!